OXFORD, England, September 25, 2013 — /PRNewswire/ --GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, today announced the appointment of Justine McQuillan as its European Director of Clinical Affairs. In this newly established position, McQuillan is leading European clinical regulatory trials of GlySure’s CBGM technology, which the company expects to complete this fall. Read more here: http://www.heraldonline.com/2013/09/25/5242825/glysure-appoints-justine-mcquillan.html#storylink=cpy
Help employers find you! Check out all the jobs and post your resume.
